GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Plans » Aetna Inc (NYSE:AET) » Definitions » Cash Flow from Financing

Aetna (AET) Cash Flow from Financing : $-2,802 Mil (TTM As of Sep. 2018)


View and export this data going back to 1968. Start your Free Trial

What is Aetna Cash Flow from Financing?

Cash from financing is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders.

For the three months ended in Sep. 2018, Aetna paid $0 Mil more to buy back shares than it received from issuing new shares. It received $0 Mil from issuing more debt. It paid $0 Mil more to buy back preferred shares than it received from issuing preferred shares. It spent $164 Mil paying cash dividends to shareholders. It spent $11 Mil on other financial activities. In all, Aetna spent $175 Mil on financial activities for the three months ended in Sep. 2018.


Aetna Cash Flow from Financing Historical Data

The historical data trend for Aetna's Cash Flow from Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aetna Cash Flow from Financing Chart

Aetna Annual Data
Trend Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17
Cash Flow from Financing
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1,525.80 -1,235.00 -1,735.00 12,134.00 -16,186.00

Aetna Quarterly Data
Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18
Cash Flow from Financing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 328.00 -1,225.00 -226.00 -1,176.00 -175.00

Aetna Cash Flow from Financing Calculation

This is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders. In the calculation of free cash flow, cash from financing is not calculated because it is not related to operating activities.

Aetna's Cash from Financing for the fiscal year that ended in Dec. 2017 is calculated as:

Aetna's Cash from Financing for the quarter that ended in Sep. 2018 is:


Cash Flow from Financing for the trailing twelve months (TTM) ended in Sep. 2018 adds up the quarterly data reported by the company within the most recent 12 months, which was $-2,802 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Aetna  (NYSE:AET) Cash Flow from Financing Explanation

Cash from financing contains six items:

1. Issuance of Stock:
A company may raise cash from issuing new shares. Issuance of stock represents the cash inflow from offering common stock, which is the additional capital contribution to the entity during the period.

Aetna's issuance of stock for the three months ended in Sep. 2018 was $0 Mil.

2. Repurchase of Stock:
A company may raise cash from issuing new shares. It can also use cash to buy back shares. Repurchase of stock represents the cash outflow to reacquire common stock during the period.

Aetna's repurchase of stock for the three months ended in Sep. 2018 was $0 Mil.

3. Net Issuance of Debt:
Net issuance of debt is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive.

Aetna's net issuance of debt for the three months ended in Sep. 2018 was $0 Mil. Aetna received $0 Mil from issuing more debt.

4. Net Issuance of Preferred Stock:
A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares. If this number is positive, it means that the company has received more cash from issuing preferred shares than it has paid to buy back preferred shares. If this number is negative, it means that company has paid more cash to buy back preferred shares than it has received for issuing preferred shares.

Aetna's net issuance of preferred for the three months ended in Sep. 2018 was $0 Mil. Aetna paid $0 Mil more to buy back preferred shares than it received from issuing preferred shares.

5. Cash Flow for Dividends:
Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

Aetna's cash flow for dividends for the three months ended in Sep. 2018 was $-164 Mil. Aetna spent $164 Mil paying cash dividends to shareholders.

6. Other Financing:
Money spent or earned by company from other financial activities.

Aetna's other financing for the three months ended in Sep. 2018 was $-11 Mil. Aetna spent $11 Mil on other financial activities.


Aetna Cash Flow from Financing Related Terms

Thank you for viewing the detailed overview of Aetna's Cash Flow from Financing provided by GuruFocus.com. Please click on the following links to see related term pages.


Aetna (AET) Business Description

Traded in Other Exchanges
N/A
Address
Aetna is one of the largest managed-care organizations in the U.S., with over 22 million medical members. This large member count helps the firm diversify its operating risk and has formed the basis for material competitive advantages. The firm provides health insurance services to its members through products that encompass every major insurance market--individual, group, and government sponsored. Aetna and CVS recently announced their intention to merge operations, and if approved, it would form one of the most powerful players within the healthcare space.
Executives
Fernando Aguirre director CHIQUITA BRANDS INTERNATIONAL, 250 EAST FIFTH STREET, CINCINNATI OH 45202
Harold L Paz officer: EVP & Chief Medical Officer AETNA INC., 151 FARMINGTON AVENUE, HARTFORD CT 06156
Molly Joel Coye director AETNA INC, 151 FARMINGTON AVENUE, HARTFORD CT 06156
Jeffrey E Garten director AETNA INC., 151 FARMINGTON AVENUE, HARTFORD CT 06156
Frank M Clark director AETNA INC., 151 FARMINGTON AVENUE, HARTFORD CT 06156
Shawn M Guertin officer: Exec. Vice President, CFO TRINET GROUP, INC., ONE PARK PLACE, SUITE 600, DUBLIN CA 94568
Mark T Bertolini director, officer: Chairman and CEO AETNA INC., 151 FARMINGTON AVENUE, HARTFORD CT 06156
Karen S Lynch officer: President 151 FARMINGTON AVENUE, RW61, HARTFORD CT 06156
Roger N Farah director POLO RALPH LAUREN CORP, 650 MADISON AVE, NEW YORK NY 10022
Ellen M Hancock director 126 LIMESTONE ROAD, RIDGEFIELD CT 06877
Edward J Ludwig director C/O BECTON DICKERSON & CO, 1 BECTON DR, FRANKLIN LAKES NJ 07417
Margaret M Mccarthy officer: EVP, Operations & Technology AETNA INC., 151 FARMINGTON AVENUE, HARTFORD CT 06156
Olympia J. Snowe director 100 E. PRATT STREET, BALTIMORE MD 21202
Heather Brianne Dixon officer: VP, Controller & CAO AETNA INC., 151 FARMINGTON AVENUE, HARTFORD CT 06156
Sabatino Thomas J Jr officer: EVP & General Counsel C/O JAN STERN REED BAXTER INTERNATIONAL, ONE BAXTER PARKWAY DF2 2W, DEERFIELD IL 60015

Aetna (AET) Headlines

From GuruFocus

Here's a Stock-Market Tool That Isn't Used Much

By John Dorfman John Dorfman 07-20-2016

Aetna: Solid Prospects in a Volatile Environment

By Robert Abbott Robert Abbott 03-31-2015

David Dreman's Top 5 Health Care Buys for the 2nd Quarter

By Sydnee Gatewood Sydnee Gatewood 08-25-2017

Paul Tudor Jones Continues to Buy Apple, Alibaba

By Tiziano Frateschi Tiziano Frateschi 11-29-2018

6 Stocks Outperforming the Market

By Tiziano Frateschi Tiziano Frateschi 10-12-2017

The Eaton Vance Fund Exits Aetna, Bristol Myers

By Tiziano Frateschi Tiziano Frateschi 01-31-2019

Aetna the Undaunted Insurer

By Mark Yu Mark Yu 10-31-2016

5 Health Care Stocks Gurus Are Buying

By Tiziano Frateschi Tiziano Frateschi 10-30-2018